Kotaieva Anastasiia's Form 4 filing
T3 Defense Inc. (DFNS) · filed Dec 22, 2025
- Accession no.
- 0001213900-25-124543
- Filed
- Dec 22, 2025
- Trade date
- Dec 18-19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $500.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kotaieva AnastasiiaCIK 0002045096 | Other: See remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −38,744 | $4.72F1 | −$182,871.68 | 1,431,197 | Indirect | |
| Dec 19, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −70,000 | $4.53F3 | −$317,100 | 1,361,197 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $5.01 to $4.67, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.695 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4
Referenced by the price of 1 transaction in Table I.
Remarks
Former director and 10% shareholder